Erasca, Inc.

ERAS

Erasca, Inc.

ERAS

Insider Sentiment (TTM):

Last Purchase:2024-05-21Last Sale:2026-04-01Shares Purchased (TTM):0Shares Sold (TTM):220,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:249,341,481Shares Outstanding:304,317,460Institutional Ownership Pct.:81.93%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	43	47	74	70	66	70	68	69	173	77	93	113
Marketable Securities Current	226	197	202	218	235	234	231	250	236	221	219	184
Prepaid Expense And Other Assets Current	10	10	10	12	10	10	10	11	10	9	8	9
Assets Current	278	254	286	300	311	315	309	330	418	307	321	306
Marketable Securities Noncurrent	116	165	66	74	86	106	142	144	52	-	10	47
Property Plant And Equipment Net	12	13	13	14	15	16	16	17	18	21	22	23
Operating Lease Right Of Use Asset	27	28	29	30	31	32	32	33	34	37	38	39
Restricted Cash Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	1	1	1	2	3	3	3	4	4	4	4	4
Assets	435	461	396	420	445	471	503	529	526	370	395	419
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	2	1	3	2	2	0	2	2	3	2	4
Accrued Liabilities And Other Liabilities	26	19	22	21	22	18	26	23	18	17	20	19
Operating Lease Liability Current	5	5	5	5	5	5	5	4	4	4	4	4
Liabilities Current	34	27	29	29	28	25	31	30	25	30	26	27
Operating Lease Liability Noncurrent	39	41	42	43	45	46	47	48	50	51	52	53
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	1	1	1
Liabilities	73	68	71	73	73	72	79	79	75	82	79	80
Stockholders Equity
Preferred Stock Value	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,483	1,470	1,217	1,210	1,204	1,197	1,191	1,184	1,155	930	923	916
Accumulated Other Comprehensive Income Loss Net Of…	-1	-1	1	1	0	1	0	2	-0	-0	0	-1
Retained Earnings Accumulated Deficit	-1,120	-1,076	-892	-863	-833	-799	-768	-735	-704	-641	-606	-576
Stockholders Equity	362	394	325	348	372	400	423	450	451	288	317	339
Liabilities And Stockholders Equity	435	461	396	420	445	471	503	529	526	370	395	419
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	80	80	80	80	80	80	80	80	80	80	80	80
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	800	800	800	800	800	800	800	800	800	800	800	800
Common Stock Shares Issued	313	311	284	284	284	283	283	283	273	151	151	151
Shares Outstanding	313	311	284	284	284	283	283	283	273	151	151	151

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	14.66%	76.92%	78.93%	-	-	-	-	-	-	-	-	-
2025	20.30%	8.27%	4.51%	3.21%	55.13%	55.13%	23.40%	35.47%	296.60%	21.57%	-31.54%	-12.35%
2024	17.21%	9.77%	52.56%	10.42%	-1.93%	5.02%	1.34%	-8.36%	-36.79%	-16.22%	-6.08%	8.11%
2023	-	-	-	-	-	-	-16.92%	5.97%	-15.92%	-13.11%	-4.37%	5.34%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.29	9.52	10.04	10.45	11.04	12.35	9.84	11.00	16.79	10.14	12.26	11.45
Quick Ratio	8.01	9.14	9.68	10.04	10.68	11.96	9.50	10.62	16.41	9.84	11.94	11.10
Working Capital	244.87M	227.12M	257.73M	271.21M	282.51M	289.15M	277.40M	300.15M	393.11M	276.38M	294.52M	279.24M
Leverage & Debt
Debt to Equity	0.20	0.17	0.22	0.21	0.20	0.18	0.19	0.18	0.17	0.28	0.25	0.24
Interest Coverage TTM	-19.42	-17.97	-8.48	-7.86	-7.25	-8.43	-8.94	-9.33	-10.00	-8.57	-8.47	-16.01
Debt Ratio	0.17	0.15	0.18	0.17	0.16	0.15	0.16	0.15	0.14	0.22	0.20	0.19
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.92	-0.91	-0.44	-0.45	-0.45	-0.56	-0.69	-0.56	-0.73	-0.84	-0.83	-1.53
Free Cash Flow Per Share TTM	-0.33	-0.30	-0.34	-0.24	-0.24	-0.38	-0.47	-0.39	-0.51	-0.72	-0.69	-0.70
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	123.91%	75.78%	-22.95%	-19.75%	-18.96%	24.23%	29.28%	-31.00%	-32.85%	-47.04%	-48.50%	47.78%
EPS Growth (1Y)	103.79%	63.61%	-36.46%	-20.12%	-37.71%	-33.70%	-16.96%	-63.24%	-53.74%	-47.62%	-58.16%	18.65%
Valuation Metrics
P/E TTM	-19.86	-17.77	-8.47	-4.84	-2.81	-2.46	-3.63	-4.84	-3.25	-2.45	-2.56	-1.29
P/B TTM	15.76	12.51	3.24	1.78	0.97	0.97	1.39	1.71	1.14	1.08	1.01	0.87
Market Cap	5.70B	4.92B	1.05B	618.43M	359.86M	388.07M	586.88M	770.91M	514.02M	311.39M	319.89M	296.39M
Enterprise Value	5.66B	4.88B	980.94M	548.20M	293.72M	317.58M	519.14M	702.03M	341.22M	234.67M	226.82M	183.52M
Calculated Values
Free Cash Flow TTM	-102.36M	-91.47M	-95.69M	-66.90M	-67.66M	-107.82M	-109.48M	-109.78M	-111.72M	-108.72M	-102.99M	-105.36M
Net Debt	-42.54M	-47.26M	-73.81M	-70.23M	-66.14M	-70.48M	-67.74M	-68.89M	-172.80M	-76.73M	-93.08M	-112.86M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-01Sale

Owner: Garner, Ebun

Title: Chief Legal Officer

Shares: 80,000

Price/Share: $16.40

Value: $1,312,000.00

Shares Owned: 25,076

Relationship: Officer

Ownership: Direct

2026-03-04Sale

Owner: Morris, Shannon

Title: Chief Medical Officer

Shares: 20,000

Price/Share: $15.04

Value: $300,800.00

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-01-07Sale

Owner: Garner, Ebun

Title: General Counsel & Corp. Sec.

Shares: 120,000

Price/Share: $5.59

Value: $670,800.00

Shares Owned: 25,076

Relationship: Officer

Ownership: Direct

2024-05-21Purchase

Owner: Casdin, Alexander W.

Title: -

Shares: 80,000

Price/Share: $2.27

Value: $181,600.00

Shares Owned: 573,974

Relationship: Director

Ownership: Direct

2023-12-06Purchase

Owner: Lim, Jonathan E

Title: Chairman & CEO

Shares: 278,150

Price/Share: $1.72

Value: $478,418.00

Shares Owned: 12,899,360

Relationship: Director,Officer,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-01	Garner, Ebun	Officer	Chief Legal Officer	Direct	Sale	80,000	16.40	$1,312,000.00	25,076	4
2026-03-04	Morris, Shannon	Officer	Chief Medical Officer	Direct	Sale	20,000	15.04	$300,800.00	0	4
2026-01-07	Garner, Ebun	Officer	General Counsel & Corp. Sec.	Direct	Sale	120,000	5.59	$670,800.00	25,076	4
2024-05-21	Casdin, Alexander W.	Director	-	Direct	Purchase	80,000	2.27	$181,600.00	573,974	4
2023-12-06	Lim, Jonathan E	Director,Officer,TenPercentOwner	Chairman & CEO	Indirect	Purchase	278,150	1.72	$478,418.00	12,899,360	4
2023-12-06	Start, Valerie Denise Har…	Director	-	Indirect	Purchase	10,000	1.85	$18,500.00	20,000	4
2023-12-04	Casdin, Alexander W.	Director	-	Direct	Purchase	30,000	1.66	$49,800.00	493,974	4
2023-10-05	Lim, Jonathan E	Director,Officer,TenPercentOwner	Chairman & CEO	Indirect	Purchase	1,000,000	2.03	$2,030,000.00	19,456,216	4
2023-06-08	Lim, Jonathan E	Director,Officer,TenPercentOwner	Chairman & CEO	Indirect	Purchase	100,000	2.75	$275,000.00	18,396,216	4
2023-04-10	Casdin, Alexander W.	Director	-	Direct	Purchase	20,000	2.76	$55,200.00	463,974	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

81.93%

Inst. Shares: 249,341,481

Shares Outstanding: 304,317,460

2025-12-31

71.38%

Inst. Shares: 202,385,400

Shares Outstanding: 283,533,696

2025-09-30

68.54%

Inst. Shares: 194,437,911

Shares Outstanding: 283,681,570

2025-06-30

69.54%

Inst. Shares: 197,058,624

Shares Outstanding: 283,355,730

2025-03-31

70.99%

Inst. Shares: 201,089,973

Shares Outstanding: 283,260,289

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	249,341,481	304,317,460	81.93%
2025-12-31	202,385,400	283,533,696	71.38%
2025-09-30	194,437,911	283,681,570	68.54%
2025-06-30	197,058,624	283,355,730	69.54%
2025-03-31	201,089,973	283,260,289	70.99%
2024-12-31	213,420,570	233,817,916	91.28%
2024-09-30	214,414,986	282,384,964	75.93%
2024-06-30	194,629,742	217,806,567	89.36%
2024-03-31	69,679,506	151,161,741	46.10%
2023-12-31	61,024,001	150,184,994	40.63%
2023-09-30	64,215,970	150,450,201	42.68%
2023-06-30	67,688,287	150,037,029	45.11%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Erasca, Inc. (ERAS) — SEC Financial Statements & Analysis

Erasca, Inc. (ERAS) is a pharmaceutical preparations company, incorporated in DE. Erasca, Inc. trades on Nasdaq as: ERAS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Erasca, Inc. reported a Debt-to-Equity ratio of 0.20x, a Price-to-Book (P/B) ratio of 15.76x (TTM), at a market cap of $5.70B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.20x
P/B TTM: 15.76x
Market Cap: $5.70B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Erasca, Inc. in?

Erasca, Inc. (ERAS) operates in the Pharmaceutical Preparations industry.

What is ERAS's market cap?

Erasca, Inc. (ERAS) has a market capitalization of $5.70B as of 2026-06-30.

What exchange does ERAS trade on?

Erasca, Inc. (ERAS) trades on the Nasdaq.

Where is Erasca, Inc. incorporated?

Erasca, Inc. is incorporated in DE.

Erasca, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Erasca, Inc. (ERAS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Erasca, Inc. (ERAS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.